$123.1 B

MDT Mkt cap, 16-Aug-2018

$30 B

Medtronic Revenue FY, 2018
Medtronic Revenue growth (FY, 2017 - FY, 2018), %1%
Medtronic Gross profit (FY, 2018)20.9 B
Medtronic Gross profit margin (FY, 2018), %69.8%
Medtronic Net income (FY, 2018)3.1 B
Medtronic EBIT (FY, 2018)6.7 B
Medtronic Cash, 27-Apr-20183.7 B
Medtronic EV143.2 B

Medtronic Revenue

Medtronic revenue was $29.95 b in FY, 2018 which is a 0.8% year over year increase from the previous period.

Embed Graph

Medtronic Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

17 b20.3 b28.8 b29.7 b30 b

Revenue growth, %

19%42%3%1%

Cost of goods sold

4.3 b6.3 b9.1 b9.3 b9.1 b

Gross profit

12.7 b14 b19.7 b20.4 b20.9 b

Gross profit Margin, %

75%69%68%69%70%

R&D expense

2.3 b

Operating expense total

2.3 b

Depreciation and amortization

1.8 b

EBIT

3.8 b5.3 b5.3 b6.7 b

EBIT margin, %

19%18%18%22%

Interest expense

108 m666 m1.4 b1.1 b1.1 b

Interest income

386 m431 m366 m397 m

Pre tax profit

4.6 b5.7 b

Income tax expense

640 m811 m798 m578 m2.6 b

Net Income

3.1 b2.7 b3.5 b4 b3.1 b

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

7.3 b7.1 b6.9 b7.2 b7.3 b7.3 b7.4 b7.1 b21.8 b

Cost of goods sold

2.5 b2.2 b2.1 b2.3 b2.3 b2.3 b2.3 b2.1 b6.7 b

Gross profit

4.8 b4.9 b4.8 b4.9 b5 b5 b5 b4.9 b15.1 b

Gross profit Margin, %

66%69%69%68%68%69%68%70%69%

R&D expense

1.7 b

Operating expense total

37.1 m1.7 b

Depreciation and amortization

1.4 b

EBIT

1.1 b1.3 b1.4 b1.2 b1.4 b1.2 b1.4 b1.9 b4.7 b

EBIT margin, %

16%18%20%16%19%16%19%27%22%

Interest expense

306 m324 m275 m272 m264 m268 m286 m273 m829 m

Interest income

115 m107 m99 m93 m91 m88 m92 m100 m290 m

Pre tax profit

(37.1 m)1.2 b1.7 b4 b

Income tax expense

120 m563 m84 m59 m101 m147 m186 m(285 m)2.3 b

Net Income

(37.1 m)820 m520 m1.1 b929 m1.1 b820 m1 b2 b1.6 b

Medtronic Balance Sheet

Annual

usdY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

13.2 m4.8 b186.4 m5 b3.7 b

Accounts Receivable

17.1 m

Inventories

1.7 b3.5 b3.5 b3.3 b3.6 b

Current Assets

21.2 b30.8 b23.6 b24.9 b23 b

PP&E

2.4 b4.7 b4.8 b4.4 b4.6 b

Goodwill

10.6 b40.5 b41.5 b38.5 b39.5 b

Total Assets

37.9 b106.7 b99.8 b99.8 b91.4 b

Accounts Payable

742 m1.6 b1.7 b1.7 b1.6 b

Short-term debt

1.6 b2.4 b993 m

Current Liabilities

5.6 b9.2 b7.2 b14.2 b10.1 b

Long-term debt

10.3 b33.8 b30.2 b25.9 b23.7 b

Total Debt

11.9 b36.2 b31.2 b25.9 b23.7 b

Total Liabilities

49.4 b40.6 b

Additional Paid-in Capital

29.6 b28.1 b

Retained Earnings

19.9 b54.4 b53.9 b23.4 b24.4 b

Total Equity

19.4 b53.2 b52.1 b50.4 b50.8 b

Debt to Equity Ratio

0.6 x0.7 x0.6 x0.5 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x0.3 x

Financial Leverage

2 x2 x1.9 x2 x1.8 x

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

46 k3 b2.4 b2.7 b3.1 b3 b2.8 b4.7 b5.5 b6.4 b

Accounts Receivable

(68 m)

Inventories

3.4 b3.5 b3.5 b3.6 b3.7 b3.7 b3.5 b3.8 b

Current Assets

46 k29.1 b28.7 b27.6 b23.5 b22.5 b22.4 b24.8 b25.2 b26.6 b

PP&E

4.7 b4.7 b4.6 b4.8 b4.9 b4.9 b4.4 b4.4 b4.5 b

Goodwill

40.7 b41.3 b40.4 b41.3 b41.7 b41.2 b39.2 b39.1 b39.8 b

Total Assets

46 k105 b105 b103 b98.6 b98.4 b97.6 b100 b94.5 b95.8 b

Accounts Payable

37 m1.3 b1.4 b1.4 b1.6 b1.7 b1.6 b1.8 b1.7 b1.8 b

Short-term debt

1.9 b2.2 b2.2 b

Current Liabilities

37 m7.7 b8.1 b8.1 b7.9 b9.6 b12.7 b15.1 b10.5 b10.9 b

Long-term debt

33.7 b33.7 b33.7 b30.1 b29 b25.9 b26 b25.9 b25.9 b

Total Debt

35.6 b35.8 b35.8 b30.1 b29 b25.9 b26 b25.9 b25.9 b

Total Liabilities

37 m51.8 b52.7 b51.9 b47.7 b48.1 b48.1 b49.5 b42.9 bwdxefcqufszuzezftuxetqsqxt45.5 b

Additional Paid-in Capital

73 k28.6 b28.1 b28.2 b

Retained Earnings

(37.1 m)54.2 b53.7 b53.8 b52.8 b52.5 b52.3 b24 b25.4 b23.4 b

Total Equity

52.8 b52.3 b50.8 b50.9 b50.3 b49.5 b50.8 b51.6 b50.3 b

Financial Leverage

2 x2 x2 x1.9 x2 x2 x2 x1.8 x1.9 x

Medtronic Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

3.1 b2.7 b3.5 b4 b3.1 b

Depreciation and Amortization

349 m1.3 b2.8 b2 b2.6 b

Accounts Receivable

(70 m)(413 m)(435 m)(75 m)(275 m)

Inventories

(39 m)(282 m)(186 m)(192 m)

Accounts Payable

(16.7 m)65 m

Cash From Operating Activities

5 b3.4 b5.2 b6.9 b4.7 b

Purchases of PP&E

(396 m)

Cash From Investing Activities

(3.6 b)(17.1 b)2.2 b(1.6 b)5.9 b

Long-term Borrowings

(565 m)(1.3 b)(5.1 b)(863 m)(7.4 b)

Cash From Financing Activities

(918 m)15.9 b(9.5 b)(3.3 b)(12 b)

Interest Paid

394 m578 m1.3 b1.1 b1.1 b

Income Taxes Paid

521 m632 m1.4 b1 b2.5 b

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q3, 2018

Net Income

(37.1 m)820 m1.3 b2.4 b929 m2 b2.9 b1 b1.6 b

Depreciation and Amortization

701 m1.4 b2.1 b737 m1.5 b2.2 b636 m2 b

Accounts Receivable

279 m(1 m)86 m196 m(89 m)18 m(88 m)19 m

Inventories

(207 m)(326 m)(388 m)(101 m)(187 m)(261 m)(318 m)

Accounts Payable

1.3 b1.4 b1.4 b13 m

Cash From Operating Activities

816 m2.1 b3.9 b1.6 b3 b5.1 b737 m3.6 b

Cash From Investing Activities

(986 m)(2.1 b)(2.3 b)(284 m)(357 m)(1.3 b)83 m5.7 b

Long-term Borrowings

(1 b)(1.6 b)(1.6 b)(17 m)(252 m)(361 m)(8 m)(4.2 b)

Cash From Financing Activities

(1.7 b)(2.5 b)(3.7 b)(1.2 b)(2.7 b)(4 b)(1.1 b)(8.1 b)

Interest Paid

76 m652 m707 m68 m559 m626 m68 m651 m

Income Taxes Paid

636 m1 b1.2 b115 m258 m474 m417 m911 m

Medtronic Ratios

USDY, 2018

EV/EBIT

21.5 x

EV/CFO

30.6 x

Financial Leverage

1.8 x
Report incorrect company information

Medtronic Operating Metrics

Medtronic's Patients was reported to be 65 m in FY, 2016.
FY, 2014FY, 2015FY, 2016

Countries

160 160

Patents Issued

27 k53 k45 k

Patients

65 m
Report incorrect company information

Medtronic Human Capital

Medtronic's employees are reported to be approximately 49% female and 51% male.
FY, 2016FY, 2015FY, 2014
Male51 %52 %51 %
Female49 %48 %49 %
Report incorrect company information